Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 8, 2001, Pages 604-610

  Martinez M A ^a   Ovalle, A ^a   Santa Cruz, A ^a   Barrera, B ^a   Vidal, R ^a   Aguirre, R ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; TETRACYCLINE;

ADULT; AMNION FLUID; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREGNANCY; UREAPLASMA; UREAPLASMA PARVUM; UREAPLASMA UREALYTICUM;

AMNIOTIC FLUID; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; TETRACYCLINE; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 0034881951     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110026782     Document Type: Article

References (46)

1. Ureaplasma urealyticum intrauterine infection: Role in prematurity and disease in newborns
2. Ureaplasma urealyticum and premature birth
3. A case control study of chorioamnionic infection and histologic chorioamnionitis in prematurity
4. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely
5. Antibiotic therapy in patients with preterm premature rupture of membranes: A prospective, randomized, placebo-controlled study with microbiological assessment of the amniotic cavity and lower genital tract
6. Premature labor with intact membranes. Relationship of amniotic fluid and lower genital tract microbiology with maternal and neonatal outcomes
7. Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates
8. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very low birth weight infants
9. Ureaplasma urealyticum gen, nov., sp.nov.: Proposed nomenclature for the human T (T-strain) mycoplasmas
10. Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans
11. Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum
12. Phylogenetic analysis of Ureaplasma urealyticum supports the establishment of a new species, Ureaplasma parvum
13. Susceptibility of Mycoplasmas to antimicrobial agents: Clinical implications
14. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates
15. TetM tetracycline-resistant determinants in Ureaplasma urealyticum
16. Clinical antibiotic resistance of Ureaplasma urealyticum
17. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis
18. Nucleotide sequence of the tetM tetracycline resistance determinant of the streptococcal conjugative shuttle transposon Tn1545
19. Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants
20. Antibiotic treatment of patients with term premature rupture of membranes: A randomized clinical trial
21. Differential agar medium (A7) for identification of Ureaplasma urealyticum (human T mycoplasmas) in primary cultures of clinical material
22. Recovery and identification of human genital tract mycoplasmas
23. Comparison of streptococci of serological group B isolated from healthy carriers and active disease in Chile
24. Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline
25. A Tn1545-like transposon carries the tet(M) gene in tetracycline resistant strains of Bacteroides ureolyticus as well as Ureaplasma urealyticum but not Neisseria gonorrhoeae
26. Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro
27. Performance standards for antimicrobial susceptibility testing M7-A4
28. Infection and labor V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes
29. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor
30. Vaginal infection and preterm labour
31. Expectant management of premature rupture of membranes with amniotic fluid cultures positive for Ureaplasma urealyticum alone
32. Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications
33. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease
34. Comparison of PCR, nested PCR, and random amplified polymorphic DNA PCR for detection and typing of Ureaplasma urealyticum in specimens from pregnant women
35. Serotype diversity and antigenic variation among invasive isolates of Ureaplasma urealyticum from neonates
36. Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents
37. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome
38. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: Results of a controlled trial of topical clindamycin cream
39. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes
40. Transplacental passage of erythromycin and clindamycin
41. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum Scand
42. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum
43. Persistence of Mycoplasma hominis after therapy: Importance of tetracycline resistance and of coexisting vaginal flora
44. Non-specific urethritis associated with a tetracycline resistant T-mycoplasma
45. Tetracycline resistant T-mycoplasmas (Ureaplasma urealyticum) from patients with a history of reproductive failure
46. The in vitro susceptibility of Ureaplasma urealyticum to antimicrobial agents